The right way to counter a poor Covaxin safety study is to publish Phase-3 trial results
Three years after the interim data were posted as a preprint, Bharat Biotech and ICMR are yet to publish any
Read More
Day: May 6, 2025
Three years after the interim data were posted as a preprint, Bharat Biotech and ICMR are yet to publish any
Read More